Clinical Trial Update: Remifentanil Versus Morphine for Sedation of Premature Neonates With Respiratory Distress Syndrome [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing remifentanil and morphine for sedation in premature neonates with respiratory distress syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• Morphine (morphine)
• Remifentanil (remifentanil)

Snippet

Sponsor: Federal University of Minas Gerais | Conditions: Respiratory Distress Syndrome | Phase 4 | Status: COMPLETED